Prescient Therapeutics LimitedASX: PTX

September 2026 Quarterly Update and Appendix 4C

· Issued by Prescient Therapeutics Limited via ASX

Filed with ASX · · 8 pages · English

Release

Suite 2 Level 11, 385 Bourke Street, Melbourne VIC 3000 Prescient Therapeutics Limited T -+61 3 9692 7222| F-+61 3 9077 9233| W – ptxtherapeutics.com ABN 56 006 569 106 September 2026 Activities Report and Appendix 4C Highlights of the Quarter: • Phase 2a study of PTX-100 in cutaneous T-cell...

Prescient Therapeutics Limited on 6ix

In the deck

Story so far

Earlier from Prescient Therapeutics

All Prescient Therapeutics news releases